502 Participants Needed

Outpatient vs Hospital Evaluation for Chest Pain

(CARE-CP Trial)

Recruiting at 2 trial locations
LK
LV
Overseen ByLauren Victory
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Wake Forest University Health Sciences
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.

What data supports the effectiveness of the treatment Hospitalization Evaluation, Inpatient Evaluation, Hospital Admission, Outpatient Evaluation, Cardiovascular Ambulatory Rapid Evaluation, CARE-CP, Outpatient Management for chest pain?

Research on same-day discharge after percutaneous coronary intervention (PCI) for stable coronary artery disease suggests that outpatient management can be effective and safe, potentially reducing hospital costs without compromising patient safety. This indicates that outpatient evaluation and management for chest pain might also be effective in certain cases, similar to the approach used in PCI.12345

Is it safe to evaluate chest pain in an outpatient setting compared to a hospital setting?

Research suggests that patients with chest pain who are evaluated as outpatients, especially those with intermediate risk scores, can be safely managed without increased risk of adverse cardiac events compared to those admitted to the hospital.678910

How does the treatment for chest pain in the 'Outpatient vs Hospital Evaluation for Chest Pain' trial differ from other treatments?

This treatment is unique because it explores managing chest pain patients with intermediate risk scores as outpatients, potentially reducing the need for hospital admission. This approach could save resources and costs while still providing timely care through rapid access chest pain clinics.911121314

What is the purpose of this trial?

The goal of this study is to determine if rapid outpatient evaluation vs hospitalization management is the best strategy (based on patient-centered measures and safe, equitable, and efficient resource use) for evaluating patients with acute chest pain who are at moderate risk for acute coronary syndrome (ACS). Patients will be randomized in the Emergency Department to either an outpatient evaluation (CARE-CP) or hospitalization evaluation for their symptoms.

Research Team

SM

Simon Mahler, MD, MS

Principal Investigator

Wake Forest University Health Sciences

Eligibility Criteria

This trial is for adults over 21 with chest pain or symptoms suggesting a moderate risk of acute coronary syndrome, but without severe heart conditions like prior heart attacks or major artery blockages. They must have normal troponin levels and no other serious health issues that require hospitalization.

Inclusion Criteria

My heart's arteries are not 70% or more blocked.
I am 21 years old or older.
I am experiencing chest pain or symptoms similar to a heart attack.
See 5 more

Exclusion Criteria

I have been diagnosed with a severe type of heart attack.
You have significant changes in your ECG, like new T-wave inversions or ST changes of 1mm or more.
Pregnancy
See 14 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week

Randomization and Initial Evaluation

Participants are randomized to either outpatient evaluation (CARE-CP) or hospitalization evaluation for their symptoms.

72 hours
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after initial evaluation, with focus on medical management for cardiovascular risk factors.

30 days
2 visits (in-person or virtual)

Long-term Follow-up

Participants are monitored for cardiovascular rehospitalizations and other outcomes at 1 year post-randomization.

1 year

Treatment Details

Interventions

  • Hospitalization Evaluation
  • Outpatient Evaluation
Trial Overview The CARE-CP study is testing whether it's better to evaluate patients with acute chest pain through rapid outpatient care or traditional hospitalization. Participants are randomly assigned to one of these two approaches in the emergency department.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Outpatient EvaluationExperimental Treatment1 Intervention
Patients randomized to this arm are discharged and receive outpatient evaluation, or cardiovascular ambulatory rapid evaluation (CARE), focused on medical management for cardiovascular risk factors (e.g. hypertension) within 72 hours of Emergency Department discharge.
Group II: Hospitalization EvaluationExperimental Treatment1 Intervention
Patients randomized to this arm receive evaluation for their symptoms in a hospital ward, observation unit, or emergency department boarding.

Hospitalization Evaluation is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Hospitalization Evaluation for:
  • Acute Chest Pain
  • Suspected Acute Coronary Syndrome (ACS)
🇪🇺
Approved in European Union as Hospital Admission for:
  • Acute Chest Pain
  • Suspected ACS
  • Cardiovascular Emergencies
🇨🇦
Approved in Canada as Inpatient Evaluation for:
  • Acute Chest Pain
  • Suspected ACS
  • Cardiac Conditions Requiring Monitoring

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Trials
415
Recruited
6,777,000+

Findings from Research

A study involving 3081 patients found that same-day discharge after percutaneous coronary interventions (PCI) did not lead to significantly different adverse cardiovascular outcomes compared to an overnight hospital stay, indicating that same-day discharge is a safe option for patients with stable coronary artery disease (CAD).
Key outcomes such as mortality, myocardial infarction, and major adverse cardiac events were similar between the two groups, suggesting that patients can be safely discharged on the same day without increased risk of complications.
Same Day Discharge versus Overnight Stay in the Hospital following Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Bundhun, PK., Soogund, MZ., Huang, WQ.[2018]
A systematic review of 13 studies involving 111,830 patients suggests that same-day discharge (SDD) after percutaneous coronary intervention (PCI) is a reasonable option for selected patients, showing no significant increase in complications compared to overnight hospitalization (ON).
However, the results showed considerable variability across studies, indicating that more extensive and well-powered trials are needed to definitively assess the safety and efficacy of SDD versus ON after PCI.
Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis.Abdelaal, E., Rao, SV., Gilchrist, IC., et al.[2022]
The study introduces the Composite Patient Encounter (CPE) as a new measure to accurately reflect hospital productivity by equating outpatient and inpatient care based on production costs.
CPE was derived from actual data and tested against other variables, showing it to be the most accurate statistic for representing overall hospital activity compared to previous measures that were limited or mixed in their approach.
What we do and how to measure it.Ford, RL.[2007]

References

Same Day Discharge versus Overnight Stay in the Hospital following Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [2018]
Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis. [2022]
What we do and how to measure it. [2007]
Early and late outcomes in patients excluded from same-day home discharge after transradial stenting and maximal antiplatelet therapy. [2016]
[Same-day discharge after elective coronary angioplasty: a single-center initial experience]. [2021]
Brief scale measuring patient preparedness for hospital discharge to home: Psychometric properties. [2015]
Discharge planning scale: community physicians' perspective. [2015]
Adverse cardiac events in emergency department patients with chest pain six months after a negative inpatient evaluation for acute coronary syndrome. [2019]
Can ED chest pain patients with intermediate HEART scores be managed as outpatients? [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Higher Emergency Physician Chest Pain Hospitalization Rates Do Not Lead to Improved Patient Outcomes. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
The chest pain emergency department and the outpatient chest pain evaluation center: revolution or evolution? [2019]
12.United Statespubmed.ncbi.nlm.nih.gov
Design and implementation of a stand-alone chest pain evaluation center within an academic emergency department. [2021]
13.United Statespubmed.ncbi.nlm.nih.gov
Outcome of chest pain patients discharged from a French emergency department: a 60-day prospective study. [2019]
Impact of Chest Pain Protocol Targeting Intermediate Cardiac Risk Patients in an Observation Unit of an Academic Tertiary Care Center. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security